IMI AMR ACCELERATOR

The #AMRAccelerator receives funding from the Innovative Medicines Initiative 2 Joint Undertaking.

- Tackling Antibiotic Resistance Together -

[IMI AMR ACCELERATOR @AMRAccelerator]

We call on government leaders, the private sector & other stakeholders to invest in #antibiotics development and #AMR research. And secure a sustainable future for efforts like the AMR Accelerator.
Read our call to action in @NatRevDrugDisc
https://t.co/cleavCzqmr

@IHIEurope

[AMR COMBINE @AMR_Combine]

One-Stop Resource for the Latest Developments Against AMR!

The ‘Webinar Archive’ page on our website is a comprehensive collection addressing antimicrobial resistance.

👉 Visit today: https://t.co/89LvFaGtz0

[AMR COMBINE @AMR_Combine]

Can’t Attend the Live Webinar on 13th February? No Problem!

👉 Submit your registration now and receive the recording to watch at a time that works best for you: https://t.co/g2IkTVT7fM

[AMR COMBINE @AMR_Combine]

Looking for a Snapshot of our Accelerator Projects?✨

The '𝗣𝗿𝗼𝗷𝗲𝗰𝘁 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗣𝗮𝗴𝗲' has it all !
The interactive table showcases detailed view of our accelerator projects aimed at combating AMR.

👉 Check out our Portfolio page now https://t.co/K3KcgwEj0m

[AMR COMBINE @AMR_Combine]

How Can We Combat Superbugs?

Hear from Nasreen Hassoun Kheir, lead author of a recent PrIMAVeRa perspective article and infectious diseases expert, as she shares her journey and insights in an exclusive interview.

👉 Read the full interview at: https://t.co/hEutFN29YH

[AMR COMBINE @AMR_Combine]

Learn how:
1️⃣ We built AntiMicrobial-KG, a knowledge graph of antibacterial assay data, and used it to train ML models to find antimicrobial compounds.
2️⃣ Our Random Forest model hit 75.9% accuracy and predicted active compounds in EU-OpenScreen and Enamine libraries.

[AMR COMBINE @AMR_Combine]

Reserve your spot today for the upcoming webinar on leveraging Machine Learning (ML)–Tool to address the challenges of antibiotic drug discovery amidst rising AMR.

Join us on February 13, 2025, 15:00 - 16:30 CET

👉 Register now to secure your spot: https://t.co/rjHApAa7CP

[IMI AMR ACCELERATOR @AMRAccelerator]

𝗙𝗶𝗻𝗱 𝗢𝘂𝘁 𝗪𝗵𝗮𝘁’𝘀 𝗔𝗵𝗲𝗮𝗱 𝗳𝗼𝗿 𝗬𝗼𝘂 𝗪𝗶𝘁𝗵 𝗨𝘀 𝗶𝗻 𝟮𝟬𝟮𝟱! ✨

Stay tuned with us for:
💻 More & More Webinars
🔬 Projects under AMR Accelerator delivering results
🧰 Updated 'News Page' on website

👉Visit our page at https://t.co/8FVgZvQZni

[IMI AMR ACCELERATOR @AMRAccelerator]

𝗦𝘁𝗮𝘆 𝗖𝗼𝗻𝗻𝗲𝗰𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 ERA4TB!

Get the latest updates and future issues from ERA4TB sent directly to your inbox.

Subscribe to their newsletter today!

🔗 https://t.co/2Vm1FCUdsl

[ERA4TB Project @IMI_ERA4TB]

As we come to the end of 2024, we would like to take this opportunity to wish all our partners, collaborators and followers a very happy Christmas and holiday season. We've achieved a lot this year & look forward to continuing our mission of developing new TB treatments in 2025!

[IMI AMR ACCELERATOR @AMRAccelerator]

Hot off the press! Our latest AMR Accelerator Newsletter is here!
In this issue, the PrIMAVeRa project is under the spotlight.

Stay informed and inspired—our newsletter is packed with insights for #AMRresearch supporters.

👉 Read it now: https://t.co/vqiKR1xV0m
#AMRaccelerator

[IMI AMR ACCELERATOR @AMRAccelerator]

Join this naming challenge to raise awareness about Neisseria gonorrhoeae, which is resistant to almost all antibiotics!
#AMRresearch

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

🚨Naming Challenge Alert 🚨

Neisseria gonorrhoeae is resistant to nearly all types of all types of antibiotics used to treat it, but YOU can help us take it down by giving it a name!

Got a fierce or funny name for this menace?
Drop it below👇Winning name takes the glory!

[IMI AMR ACCELERATOR @AMRAccelerator]

Stay in the loop: https://t.co/ceqzwEfBYs

Sign up for our newsletter and get the latest updates, insights, and exclusive content delivered straight to your inbox!

[IMI AMR ACCELERATOR @AMRAccelerator]

Today starts World AMR Awareness Week 2024!

Our public-private partnership urges government leaders and private actors to invest in developing antibiotics and research on antimicrobial resistance: https://t.co/cleavCzqmr

#WAAW #AntimicrobialResistance.

[IMI AMR ACCELERATOR @AMRAccelerator]

Today starts World AMR Awareness Week 2024!

Our public-private partnership urges government leaders and private actors to invest in developing antibiotics and research on antimicrobial resistance: https://t.co/cleavCzqmr

#WAAW #AntimicrobialResistance.

[AMR COMBINE @AMR_Combine]

Our consortium member grit42 announced that the grit Scientific Data Management Platform will be released for free!
Platforms like this drive #collaboration and #sustainability of #AMRresearch while promoting #OpenScience and #innovation.

Read more: https://t.co/yhWF4mebJ9

[AMR COMBINE @AMR_Combine]

The fifth COMBINE Annual meeting gathered on October 28-29 in Madrid for an update on the main achievements and an outlook plan to ensure the project’s legacy beyond its lifetime.

[IMI AMR ACCELERATOR @AMRAccelerator]

Mycobacterium avium and M. abscessus cause millions of infections worldwide, with up to 30% mortality rates.
There are no effective #antibiotics to treat infections. #RespiriNTM calls for long-term investment in R&D, now with a new partner @Bioversys!

https://t.co/c44xHYnKCc

[BioVersys @Bioversys]

BioVersys announces joining the @AMRAccelerator EU-funded programme @RespiriNTM, access to up to €2 m in non-dilutive funding for our broad-spectrum NTM project. Read the full press release here: https://t.co/zFUoKAuQtY
#SavingLivesinResistantTimes #AMR #investment #Innovation

[ERA4TB Project @IMI_ERA4TB]

3 Weeks to go until our #workshop at #UnionConf2024 . Come and see us and our panel of expert speakers on the 12th November between 10:30-13:00.
The workshop is free for attendees at the conference and can be booked during registration.
➡️ Register here: https://t.co/ISXcAPLkFP

[IMI AMR ACCELERATOR @AMRAccelerator]

Accessing content from Nature Reviews Drug Discovery requires a subscription. Therefore, we are providing free access to a digital reprint of the article from our website: https://t.co/GWBkdUW7Ff

[IMI AMR ACCELERATOR @AMRAccelerator]

We call on government leaders, the private sector & other stakeholders to invest in #antibiotics development and #AMR research. And secure a sustainable future for efforts like the AMR Accelerator.
Read our call to action in @NatRevDrugDisc
https://t.co/cleavCzqmr

@IHIEurope

[IMI AMR ACCELERATOR @AMRAccelerator]

#Antibiotic resistance is a global public health threat. The PrIMAVeRa project’s mathematical models can help predict the effects of #vaccines and monoclonal antibodies on the reduction of #AMR.

Read more 👉 https://t.co/5pMW51wjtc

#PublicHealth #GlobalHealth #VaccinesWork